What is Tofersen: Uses, Dosage, Side Effects and More

Tofersen is a specialized medication designed to treat a specific type of ALS (amyotrophic lateral sclerosis) caused by mutations in the SOD1 gene. This groundbreaking treatment works by targeting the root cause of the disease at the genetic level, offering hope for patients with this rare but devastating condition.

Unlike traditional ALS treatments that focus on managing symptoms, tofersen represents a new approach called antisense therapy. It's delivered directly into the spinal fluid through a procedure similar to a spinal tap, allowing the medication to reach the brain and spinal cord where it's needed most.

What is Tofersen?

Tofersen is an antisense oligonucleotide medication that specifically targets SOD1-ALS, a form of ALS caused by mutations in the SOD1 gene. This gene mutation accounts for about 2% of all ALS cases, making it relatively rare even within the ALS community.

The medication works like a molecular pair of scissors, cutting up the harmful SOD1 protein before it can damage nerve cells. Think of it as intercepting a toxic message before it can cause harm to your motor neurons - the cells that control muscle movement.

Tofersen received FDA approval in 2023 under the brand name Qalsody, marking a significant milestone in ALS treatment. It's the first therapy designed to address the underlying genetic cause of SOD1-ALS rather than just managing symptoms.

What is Tofersen Used For?

Tofersen is specifically used to treat adults with ALS caused by mutations in the SOD1 gene. This isn't a treatment for all types of ALS - it only works for the specific subset caused by SOD1 mutations.

Before starting tofersen, you'll need genetic testing to confirm you have a SOD1 mutation. Your doctor will order a simple blood test to check for these specific genetic changes. Only patients with confirmed SOD1 mutations are candidates for this treatment.

The medication aims to slow the progression of ALS by reducing the production of toxic SOD1 protein in your nervous system. While it's not a cure, clinical studies suggest it may help preserve nerve function and slow the decline in muscle strength and function.

How Does Tofersen Work?

Tofersen works through a process called antisense therapy, which targets the genetic instructions that create harmful proteins. In SOD1-ALS, mutated genes produce toxic versions of the SOD1 protein that damage motor neurons.

The medication binds to the SOD1 messenger RNA - think of this as the instruction manual your cells use to make proteins. By binding to these instructions, tofersen prevents your cells from making the toxic SOD1 protein that's causing nerve damage.

This approach is considered a strong, targeted therapy because it addresses the root cause of the disease rather than just treating symptoms. However, it's important to understand that tofersen is highly specific - it only works for SOD1-related ALS and won't help with other forms of the disease.

How Should I Take Tofersen?

Tofersen is given as an injection directly into your spinal fluid through a procedure called intrathecal administration. This isn't something you can do at home - it requires a medical procedure performed by trained healthcare professionals.

The injection process is similar to a spinal tap or lumbar puncture. You'll lie on your side or sit leaning forward while a doctor inserts a thin needle into your lower back to access the spinal fluid. The medication is then slowly injected into this space.

You don't need to do anything special before the procedure regarding food or drink, but your doctor may give you specific instructions. The procedure typically takes about 15-30 minutes, and you'll need to rest lying flat for a period afterward to reduce the risk of headaches.

How Long Should I Take Tofersen For?

Tofersen is typically given as an ongoing treatment for as long as you and your doctor determine it's beneficial. The initial treatment schedule usually involves more frequent doses, followed by maintenance dosing every few months.

Most patients start with a loading phase of three doses given over several weeks, followed by maintenance doses every 12 weeks. Your doctor will monitor your response to treatment and may adjust the timing based on how you're doing.

Because ALS is a progressive disease, treatment decisions are highly individualized. Your healthcare team will regularly assess whether the benefits of continuing treatment outweigh any side effects or complications you might experience.

What Are the Side Effects of Tofersen?

Like all medications, tofersen can cause side effects, though not everyone experiences them. The most common side effects are related to the injection procedure itself and the medication's effects on the nervous system.

Here are the side effects you might experience, ranging from most common to less frequent:

• Headache - often related to the spinal injection procedure
• Back pain or soreness at the injection site
• Fatigue or feeling unusually tired
• Nausea or upset stomach
• Fever or flu-like symptoms
• Dizziness or feeling lightheaded

These common side effects usually improve within a few days after each injection. Your healthcare team will monitor you closely and can provide treatments to help manage these symptoms if they occur.

Some patients may experience more serious but rare side effects that require immediate medical attention:

• Severe headache that doesn't improve with rest or medication
• Signs of infection at the injection site (increased redness, warmth, or pus)
• Persistent nausea and vomiting
• Changes in vision or severe dizziness
• Difficulty breathing or chest pain

If you experience any of these serious symptoms, contact your healthcare provider immediately. They're equipped to help you manage these effects and determine the best course of action.

Who Should Not Take Tofersen?

Tofersen isn't suitable for everyone, even among those with ALS. The most important factor is that you must have confirmed SOD1 mutations - genetic testing is essential before starting treatment.

You shouldn't receive tofersen if you have certain medical conditions that make the injection procedure risky. These include active infections near the injection site, blood clotting disorders, or if you're taking certain blood-thinning medications that can't be safely stopped.

Your doctor will also carefully consider your overall health status. If you have advanced ALS with significant breathing difficulties or other serious health complications, the risks of the procedure might outweigh the potential benefits.

Pregnancy and breastfeeding require special consideration. While there's limited data on tofersen's safety during pregnancy, your doctor will weigh the potential benefits against unknown risks if you're pregnant or planning to become pregnant.

Tofersen Brand Name

Tofersen is marketed under the brand name Qalsody by Biogen, the pharmaceutical company that developed this medication. You might hear healthcare providers refer to it by either name - tofersen or Qalsody.

The brand name Qalsody is specifically used for the intrathecal formulation, which is the version delivered directly into the spinal fluid. This is currently the only available form of tofersen.

Tofersen Alternatives

Currently, there are no direct alternatives to tofersen for treating SOD1-ALS. This medication represents the first and only approved treatment specifically targeting this genetic form of ALS.

However, patients with SOD1-ALS can still benefit from other ALS treatments and supportive care. These include riluzole and edaravone, which are approved for all forms of ALS and may provide additional benefits when used alongside tofersen.

Your care team will likely recommend a comprehensive approach that includes physical therapy, respiratory support, nutritional guidance, and other supportive treatments. These complementary therapies work together with tofersen to help maintain your quality of life.

Is Tofersen Better Than Riluzole?

Tofersen and riluzole work in completely different ways, so they're not directly comparable medications. Riluzole is approved for all forms of ALS and works by reducing nerve cell damage, while tofersen specifically targets SOD1 mutations.

Many patients with SOD1-ALS may benefit from taking both medications together. Riluzole provides general neuroprotection, while tofersen addresses the specific genetic cause of SOD1-ALS. Your doctor can help determine the best combination of treatments for your situation.

The advantage of tofersen is that it targets the root cause of SOD1-ALS rather than just treating symptoms. However, it's only effective for people with SOD1 mutations, making it a more specialized but potentially more targeted treatment option.